HVC
SGNT

Healthcare Value Capital’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Healthcare Value Capital’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-50,000
Closed -$749K – 29
2016
Q2 		$749K Hold
50,000
– – 0.91% 17
2016
Q1 		$609K Buy
+50,000
New +$701K 0.89% 20
2014
Q1 		– Sell
-58,722
Closed -$1.49M – 52
2013
Q4 		$1.49M Sell
58,722
-15,100
-20% -$341K 1.09% 21
2013
Q3 		$1.51M Sell
73,822
-29,100
-28% -$648K 1.32% 31
2013
Q2 		$2.16M Buy
+102,922
New +$1.84M 1.57% 22

Healthcare Value Capital's SGNT Position: Q3 2016 in Review

Healthcare Value Capital sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 50,000 shares — an estimated $749K sold.

Healthcare Value Capital first reported a position in SGNT in Q2 2013 and held it in 5 quarters. The position peaked at $2.16M in Q2 2013. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • Healthcare Value Capital reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Healthcare Value Capital sold 50,000 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $749K.
  • Healthcare Value Capital first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
  • Healthcare Value Capital's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $2.16M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Healthcare Value Capital's 13F filing for Q3 2016, filed 10 Nov 2016.